Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2001-1326
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer ; volume:3 ; number:1 ; day:28 ; month:10 ; year:2014 ; pages:1-6 ; date:12.2014
Clinical and translational medicine ; 3, Heft 1 (28.10.2014), 1-6, 12.2014

Urheber
El Demery, Mounira
Demirdjian-Sarkissian, Gaiané
Thezenas, Simon
Jacot, William
Laghzali, Yassine
Darbouret, Bruno
Culine, Stéphane
Rebillard, Xavier
Lamy, Pierre-Jean
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40169-014-0031-4
URN
urn:nbn:de:101:1-2019080304550824504226
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:22 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • El Demery, Mounira
  • Demirdjian-Sarkissian, Gaiané
  • Thezenas, Simon
  • Jacot, William
  • Laghzali, Yassine
  • Darbouret, Bruno
  • Culine, Stéphane
  • Rebillard, Xavier
  • Lamy, Pierre-Jean
  • SpringerLink (Online service)

Ähnliche Objekte (12)

SPON1 is an independent prognostic biomarker for ovarian cancer

SPON1 is an independent prognostic biomarker for ovarian cancer

The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer

The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer

CXCL10 could be a prognostic and immunological biomarker in bladder cancer

CXCL10 could be a prognostic and immunological biomarker in bladder cancer

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer

Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer

SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy

SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy

Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer

Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma

SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer

SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma

PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma

Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma

Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma

Verbundene Objekte